David Johnstone, MD
Dr. David Johnstone is a thoracic and cardiothoracic surgeon at the Froedtert Hospital and Medical College of Wisconsin, where he provides technical surgical expertise to patients diagnosed with lung cancer, lung tumors, esophageal cancers, and other thoracic malignancies including malignant pleural mesothelioma. Dr. Johnstone has been practicing for over twenty years and says that his goal is to provide each of his patients with a clear understanding of his or her illness and the treatment choices available to them.[1]
Dr. Johnstone has been the director of the thoracic disease committee at Froedtert’s cancer center since 2011. He oversees a multidisciplinary team made up of surgical, medical, and radiation oncology specialists who work together at a weekly tumor board to determine and then present patients with a full consultation and treatment plan aligned to what is in each one’s particular situation and condition.
Education and Career
Dr. Johnstone completed his undergraduate education at Yale University in New Haven, Connecticut, and then went on to medical school at Northwestern University in Chicago. His internship and residency in General Surgery were completed at Columbia Presbyterian Medical Center in New York City and his Cardiothoracic residency was completed at Memorial Sloan Kettering Cancer Center and Cornell University Medical Center.[1]
After completion of his medical education and training, Dr. Johnstone spent twelve years as a thoracic surgeon at the University of Rochester Medical Center. He then joined the Dartmouth Hitchcock Medical Center and its associated Norris Cotton Cancer Center in Lebanon, New Hampshire, where he spent seven years as the Director of the Comprehensive Thoracic Oncology Program and Chief of the Division of Thoracic Surgery.
Research
Dr. Johnstone’s academic and research interests are treatments for lung cancer, esophageal cancer, and other thoracic malignancies. His most recent publications include:[2]
Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer.. Thomas Matoska, Anjishnu Banerjee, Aditya Shreenivas, Lauren Jurkowski, Monica E Shukla, Elizabeth M Gore, Paul Linsky, Mario Gasparri, Ben George, Candice Johnstone, …>; Cancers. 2023 Apr 28
A Case of Unicentric Castleman Disease with Concomitant Myasthenia Gravis and Persistent Left Superior Vena Cava.. Maxwell Cardwell, Marvin S Lu, Joshua Melamed, John Astle, Mario Gasparri, David W Johnstone>;The American Journal of Case Reports. 2023 Feb 2
Thoracic chordoma in a 36-year-old female.. Austin C Kassels, Joshua Melamed, Austin Rogers, David Johnstone>; Journal of Surgical Case Reports. 2022 Dec 1
Terri Heimann Oppenheimer
WriterTerri Oppenheimer has been writing about mesothelioma and asbestos topics for over ten years. She has a degree in English from the College of William and Mary. Terri’s experience as the head writer of our Mesothelioma.net news blog gives her a wealth of knowledge which she brings to all Mesothelioma.net articles she authors.
Dave Foster
Page EditorDave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.
References
- Froedtert. (N.D.). David Johnstone, MD.
Retrieved from: https://www.froedtert.com/doctors/david-johnstone-1366470627 - Doximity. (N.D.). David Johnstone, MD.
Retrieved from: https://www.doximity.com/pub/david-johnstone-md